Sensei Biotherapeutics
SNSE
SNSE
23 hedge funds and large institutions have $1.16M invested in Sensei Biotherapeutics in 2024 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 10 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
90% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 10
Holders
23
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$24K | |
| 2 | +$8.09K | |
| 3 | +$5K | |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
+$78 |
Top Sellers
| 1 | -$28.8K | |
| 2 | -$27.3K | |
| 3 | -$25.7K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$11.9K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$6.99K |